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ABSTRACT
Adipocytes promote cancer progression and impair treatment, and have been 
shown to protect acute lymphoblastic leukemia (ALL) cells from chemotherapies. Here 
we investigate whether this protection is mediated by changes in oxidative stress. 
Co-culture experiments showed that adipocytes protect ALL cells from oxidative stress 
induced by drugs or irradiation. We demonstrated that ALL cells induce intracellular 
ROS and an oxidative stress response in adipocytes. This adipocyte oxidative stress 
response leads to the secretion of soluble factors which protect ALL cells from 
daunorubicin (DNR). Collectively, our investigation shows that ALL cells elicit an 
oxidative stress response in adipocytes, leading to adipocyte protection of ALL cells 
against DNR.
INTRODUCTION
Excess body weight contributes to as many as 1 out 
of 5 of all cancer-related deaths [1]. A landmark paper by 
Calle et al. found a significant association between obesity 
and mortality from many types of cancer [2]. Many solid 
tumors reside in locations rich with adipocytes, including 
breast, ovarian, pancreatic, colon, and prostate cancers, 
and some studies have shown that adipocytes interact with 
cancer cells [3–6]. Obesity has also shown to be associated 
with poorer event-free survival in the hematological 
cancer, acute lymphoblastic leukemia (ALL) [7–9], and 
we and others have demonstrated that leukemia/lymphoma 
cells can be found in close proximity to adipocytes in the 
bone marrow [10–12] and adipose tissue [13–15]. We also 
showed that adipocytes protect ALL cells from a variety of 
chemotherapeutic agents, though the mechanisms of this 
protection remain unclear [16, 17]. Here, we investigate 
the role of adipocytes in alleviating oxidative stress caused 
by chemotherapy treatment in ALL cells.
Cancer cells contain increased intracellular reactive 
oxygen species (ROS) due to metabolic and signaling 
aberrations [18, 19]. This increased ROS can have both 
beneficial and detrimental effects [20, 21]. Cancer cells 
maintain a balance of ROS by activation of oxidative 
stress response genes, many of which are regulated by 
the transcription factor nuclear factor erythroid 2-related 
factor 2 (Nrf2) [22, 23]. The increased expression of 
oxidative stress response genes contributes to cancer 
cell resistance to chemotherapies such as anthracyclines 
[24, 25], which work in part by inducing oxidative stress. 
Given the significant protection that adipocytes provide 
to ALL cells, particularly against the anthracycline 
daunorubicin (DNR) [16], we investigated whether 
adipocytes protect ALL cells from chemotherapies by 
relieving oxidative stress.
RESULTS
Adipocytes protect ALL cells from oxidative 
stress-induced cell death
We have previously reported that murine 3T3-L1 
adipocytes protect murine ALL cells (8093) [26] from 
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DNR in a direct co-culture system [16]; however, we did 
not test whether protection against DNR requires cell-
cell contact, nor did we test whether this occurs with 
human ALL cell lines. Therefore, we cultured ~2 × 105 
mouse (8093) and human (BV173, RS4;11, and Nalm6) 
ALL cells in TransWells above 3T3-L1 adipocytes, 
preadipocytes (fibroblasts), or no feeder layer. Transwells 
contained polycarbonate membranes with 0.4 μm pores, 
allowing free diffusion of media without direct cell-cell 
contact. Adipocytes protected mouse and human ALL cells 
from DNR, compared to no feeder and pre-adipocytes 
(Figure 1A). The human adipocyte Chub-S7 cell line 
also protected human ALL cells against DNR in similar 
transwell cultures. While 24 hours of DNR treatment led 
to increased cleaved caspase 3 in BV173 cells, indicating 
apoptosis by the intrinsic pathway, this was reversed in the 
presence of adipocytes (Figure 1B). 3T3-L1 adipocytes 
also protected BV173 ALL cells from the anthracycline 
doxorubicin (Figure 1C). 
Our data indicates that direct cell-cell contact is 
not necessary for the protection against DNR, implying 
the existence of soluble factors mediating this protection. 
Surprisingly, we found that adipocyte conditioned media 
(ACM) did not protect ALL cells from DNR (Figure 1D). 
However, media conditioned by both adipocytes and 
leukemia cells simultaneously (ALCM) protected 8093 
and BV173 from DNR treatment compared to both control 
media and ACM (Figure 1D), and reduced DNR induced 
cleavage of caspase 3 in 8093 cells (Figure 1E). Similar 
results were observed when media was conditioned 
serially by ALL cells and then adipocytes (not shown). 
ALCM also protected ALL cells from apoptosis as 
measured by Annexin V, though this did not reach 
statistical significance in BV173 cells (Figure 1F). 
Together, these results imply that adipocytes release 
protective factors when stimulated by ALL cells. 
Since DNR is a potent inducer of ROS [27], which 
contributes to its cytotoxicity, we next investigated 
whether adipocytes prevented DNR induction of ROS. 
We used DCFH-DA to directly measure intracellular ROS 
in Nalm6 cells during DNR treatment. DNR induced 
intracellular ROS within 6 hours in a dose-dependent 
manner, and this was significantly reduced in the presence 
of adipocytes, but not fibroblasts (Figure 2A). A similar 
pattern was observed in using the dye CellRox®, which 
demonstrated that ALCM protected all three human 
ALL cell lines from the DNR induction of intracellular 
ROS (Figure 2B). ALL cells exhibited an oxidative 
stress response after DNR treatment, as demonstrated 
by an increase in gene expression of the two subunits of 
the glutathione producing enzyme, glutamate cysteine 
ligase (GCLC and GCLM, Figure 2C). However, co-
culturing with either 3T3-L1 or Chub-S7 adipocytes 
reversed the induction of these oxidative stress response 
genes (Figure 2C). Interestingly, expression of both 
genes decreased slightly, but significantly, in 8093 cells 
co-cultured with adipocytes without DNR treatment (black 
bar vs. white bar), potentially indicating alleviation of the 
basal level of oxidative stress. A similar pattern of GCLC 
and GCLM expression was also observed with Nalm6 
ALL cells (data not shown).
To test whether adipocyte protection of ALL cells 
from oxidative stress was specific to that induced by DNR, 
we used additional inducers of oxidative stress. ALL cells 
were treated with chaetocin, a fungal-derived toxin that 
inhibits thioredoxin reductase-1, leading to increased 
cellular oxidative stress. Adipocytes significantly 
protected all three ALL cell lines from chaetocin induced 
cell death (Figure 2D). We also found that co-culturing 
with adipocytes modestly improved the viability of 
BV173 ALL cells that had been irradiated with 12 and 
18 Gy (Figure 2E), though in this case adipocytes did not 
offer significantly more protection than pre-adipocytes. 
Although both chaetocin and irradiation cause insults 
besides just oxidative stress, these results are consistent 
with the findings that adipocytes protect ALL cells from 
oxidative stress induced cytotoxicity.
ALL cells induce oxidative stress in adipocytes
To investigate how ALL cells stimulate adipocytes 
to secrete protective factors, we exposed adipocytes 
to leukemia cell conditioned media (LCM) for 
24 hours, and performed Affymetrix microarray 
analysis on the adipocytes. We found 3,528 significant 
gene expression changes (p < 0.05) in the adipocytes, 
including upregulation of many genes in the oxidative 
stress response pathway (Table 1 shows the top 10 most 
upregulated genes, ranked by fold change). Ingenuity 
Pathway Analysis (IPA) identified the Nrf2-mediated 
oxidative stress response to be one of the most affected 
pathways in adipocytes, with 47 genes differentially 
regulated down-stream of the pathway (Ingenuity® 
Systems, www.ingenuity.com, Table 2), implying that 
ALL cells were inducing oxidative stress in adipocytes. 
To directly test whether ALL cells induce oxidative stress 
in adipocytes, we visualized adipocyte intracellular ROS 
with DCFH-DA using fluorescence confocal microscopy. 
After 48 hours of co-culture with BV173 cells in a 
TransWell system, adipocytes had increased intracellular 
ROS (Figure 3A and 3B), to a similar degree as adipocytes 
treated with buthionine sulfoximine (BSO) as a positive 
control. Co-culture with ALL cells also induced a 
significant upregulation of the oxidative stress response 
genes, HO-1 and ADM, and a non-statistically significant 
increase in Mt2 gene expression (Figure 3C), as well as 
increased HO-1 protein levels (Figure 3D), confirming 
our microarray findings. Consistent with this, glutathione 
concentration in media conditioned by 3T3-L1 adipocytes 
together with BV173 ALL cells for 48 hours was higher 
than media conditioned by adipocytes or leukemia cells 
alone (Figure 3E).
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ALL cell induction of oxidative stress in 
adipocytes induces their protection of ALL cells 
from DNR 
To test whether ALL induction of oxidative stress 
response in adipocytes induces their protection of ALL 
cells, we treated adipocytes with cobolt chloride, a 
hypoxia mimetic which stabilizes HIF1α and induces an 
antioxidant response [28]. CoCl2 treatment was associated 
with increase in adipocyte HIF-1α protein levels and 
gene expression of HO-1, GCLC, and GCLM (Figure 4A 
and 4B). 3T3-L1 and ChubS7 conditioned media made 
in the presence of 30µM cobalt chloride (w/ CoCl2) were 
protective of ALL cells against DNR, compared to both 
Figure 1: Adipocytes protect ALL from oxidative stress induced cell death. (A) ALL cells co-cultured in TransWells over 
3T3-L1 and ChubS7 pre-adipocytes (hatched bars) and adipocytes (black bars) with 72 hour DNR treatment (8093 35 nM, BV173 100 nM, 
RS4;11 100 nM, and Nalm6 200 nM). No feeder condition is where ALL cells were cultured alone (n = 3–5). (B) One representative image 
of western blot of Caspase 3 (37 kDa) and cleaved caspase 3 (19 and 17 kDa) in BV173 cells treated with DNR for 24 hours in the presence 
or absence of adipocytes. Images were histogram stretched in a consistent manner to increase brightness for publication. Quantification of 
the ratio of cleaved (both bands) over total caspase 3 (band at 37 kDa) is shown on the right (n = 3). (C) BV173 ALL cells cultured over 
3T3-L1 cells and treated with various doses of doxorubicin (Dox). (D) 8093 cells treated with 35 nM DNR in 3T3-L1 ACM and ALCM 
(left, n = 6); BV173 cells treated with 100 nM DNR in ChubS7 ACM and ALCM (right, n = 5). (E) Quantification of cleaved over total 
caspase 3 of 8093 ALL cells after 24 hours treatment with 25 nM DNR with and without ALCM. (F) Annexin V staining of human ALL 
cells after 24 hour exposure to DNR with or without ALCM. *P < 0.05, **P < 0.01, ***P < 0.001 All asterisks indicate comparison to 
control no feeder (NF gray bar) or no DNR no adipocyte conditions (white bar) unless otherwise indicated.
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ACM (Figure 4C), and ACM to which CoCl2 was added 
after conditioning as a control (+ CoCl2). Thus, induction 
of oxidative stress response by CoCl2 induces adipocytes 
to secrete factors which protect ALL cells from DNR.
To further hone in on which aspects of the 
adipocyte oxidative stress response are responsible for 
their protection of ALL cells against DNR, we blocked 
parts of the oxidative stress response in adipocytes 
prior to coculturing with ALL cells. BSO, an inhibitor 
of glutamylcysteine ligase, completely suppressed 
intracellular GSH levels in adipocytes, while auranofin 
(AUR), an inhibitor of thioredoxin reductase, actually 
Figure 2: Adipocytes protect ALL cells from oxidative stress. (A) Measurement of % ROShigh population in Nalm6 cells treated 
with DNR for 6 hours. % ROShigh based on gates defined by cells without DNR treatment. Adipo condition is significantly different than 
both Fibro and No Feeder by repeated measure ANOVA (p < 0.05). (B) CellRox® intensity by flow cytometry measures intracellular ROS 
after 24 hours exposure to DNR or DNR plus ALCM. (C) GCLC and GCLM gene expressions by qPCR in 8093 and BV173 cells treated 
with DNR, with or without adipocytes present (n = 3). Asterisks and p-values indicate comparisons to the no-daunorubicin, no 3T3-L1 
condition (white bar), unless otherwise noted. (D) ALL cells co-cultured with 3T3-L1 pre-adipocytes and adipocytes with chaetocin 
treatment (BV173 and Nalm6 100 nM, RS4;11 50 nM, n = 3–4). (E) Irradiated BV173 ALL cells co-cultured with 3T3-L1 pre-adipocytes 
and adipocytes (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.
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Table 1: Top 10 most upregulated genes ranked by fold change from Affymetrix microarray 
analysis of data comparing gene expression changes in 3T3-L1 adipocytes exposed to LCM for 
24 hours to control 3T3-L1 adipocytes
Gene symbol Name Fold change P-value
Mt2 Metallothionein 2 4.6 0.02
Aldh1l2 Aldehyde dehydrogenase 1 family, member l2 3.6 0.00004
Adm Adrenomedullin 3.5 0.0006
Trib3 Induced in fatty liver dystrophy 2 3.1 0.002
Eno2 Enolase 2, gamma neuronal 3.0 0.00002
Hmox1 Heme oxygenase (decycling) 1 2.7 0.0001
Ddit3 Dna-damage inducible transcript 3 2.7 0.0003
Myd116 Myeloid differentiation primary response gene 116 2.6 0.0003
Car6 Carbonic anhydrase 6 2.5 0.004
Got1 Glutamate oxaloacetate transaminase 1, soluble 2.5 0.003
Table 2: Forty-seven differentially regulated genes in the Nrf-2 mediated oxidative stress response 
pathway identified by IPA
Symbol Entrez gene name Fold change p-value
HMOX1 heme oxygenase (decycling) 1 2.738 1.30E-04
GCLC glutamate-cysteine ligase, catalytic subunit 2.020 2.40E-03
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 2.007 1.63E-03
NQO1 NAD(P)H dehydrogenase, quinone 1 1.999 3.85E-03
FMO1 flavin containing monooxygenase 1 −1.779 2.97E-03
ATF4 activating transcription factor 4 1.740 4.28E-04
PIK3R3 phosphoinositide-3-kinase, regulatory subunit 3 (gamma) −1.734 6.34E-03
MAFF v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F 1.618 1.54E-02
MGST3 microsomal glutathione S-transferase 3 −1.569 5.49E-03
GCLM glutamate-cysteine ligase, modifier subunit 1.541 1.19E-03
EPHX1 epoxide hydrolase 1, microsomal (xenobiotic) 1.502 9.86E-04
ACTG2 actin, gamma 2, smooth muscle, enteric −1.493 2.22E-02
HERPUD1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 1.484 7.61E-03
MAP3K1 mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase 1.477 3.31E-03
ACTA2 actin, alpha 2, smooth muscle, aorta −1.440 1.53E-02
SQSTM1 sequestosome 1 1.435 8.34E-04
MAFG v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G 1.431 3.91E-02
PRKCD protein kinase C, delta 1.428 3.99E-03
TXNRD1 thioredoxin reductase 1 1.414 2.83E-03
HSPB8 heat shock 22kDa protein 8 1.413 3.38E-04
MAP2K1 mitogen-activated protein kinase kinase 1 1.408 1.56E-04
PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (alpha) −1.406 1.68E-02
DNAJA3 DnaJ (Hsp40) homolog, subfamily A, member 3 1.398 3.47E-03
SCARB1 scavenger receptor class B, member 1 −1.374 2.06E-02
GSTO1 glutathione S-transferase omega 1 1.362 2.05E-02
DNAJC15 DnaJ (Hsp40) homolog, subfamily C, member 15 −1.301 3.46E-02
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increased GSH levels, likely a compensatory effect from 
blocking thioredoxin synthesis (Figure 5A). Neither 
treatment resulted in visible morphological changes to 
the adipocytes. ALL cells and LCM had no measurable 
effect on adipocyte GSH levels. Pretreatment of 3T3-L1 
adipocytes with BSO only partially reversed their ability 
to protect BV173 and Nalm6 against DNR (Figure 5B). 
Similar results were observed with ChubS7 human 
adipocytes (Figure 5C). However, pretreatment of 3T3-L1 
adipocytes with AUR did not affect DNR protection 
(Figure 5D), nor did it add to the effect of BSO to reduce 
adipocyte protection (not shown). Taken together, these 
results demonstrate that GSH synthesis may partly 
contribute to the adipocyte’s ability to protect ALL cells 
from DNR.
Exogenous antioxidants protect ALL cells from 
DNR
As a proof of principle, we next tested whether 
reduction of ALL cell oxidative stress alone could protect 
ALL cells against DNR. Supplementation with high 
concentration (20 mM) of GSH significantly increased the 
number of viable cells after DNR treatment of BV173, 
Nalm6 (Figure 6A), and RS4;11 (data not shown) ALL 
cells. N-acetylcysteine (NAC), a GSH precursor, also 
protected these cells from DNR (Figure 6B), and was 
associated with increased viability assessed by flow 
cytometry (Figure 6C). NAC also partially reversed the 
induction of intracellular ROS caused by DNR treatment, 
measured by CellROX®, though this did not reach 
statistical significance in Nalm6 cells (Figure 6C). 
DISCUSSION
In the present study, we demonstrate that ALL cells 
induce oxidative stress in adipocytes, which causes them 
to protect the ALL cells from oxidative stress, in turn 
promoting resistance to the anthracycline, daunorubicin 
(DNR). These findings add to the growing literature 
which implicates adipocytes as an active and important 
component of the microenvironment of some cancers, such 
as breast cancer, ovarian cancer, and chronic lymphocytic 
leukemia [3–6, 29]. Since adipocytes are highly prevalent 
in the microenvironments of these cancers (breast, 
peritoneum, bone marrow), this phenomenon could 
contribute to cancer cell resistance to chemotherapy in 
patients. 
Our results have uncovered a two-way 
communication between ALL cells and adipocytes, 
apparently initiated by ALL cell induction of oxidative 
stress in adipocytes. There is an expanding literature 
showing that cancer cells can alter the phenotypes of 
cells in their microenvironment, for example by inducing 
the development of “cancer-associated fibroblasts” 
[30–32]. Some of this interaction may be mediated by 
MAPK7 mitogen-activated protein kinase 7 1.284 1.06E-02
CAT catalase −1.271 1.84E-02
DNAJB2 DnaJ (Hsp40) homolog, subfamily B, member 2 1.262 2.98E-02
DNAJC16 DnaJ (Hsp40) homolog, subfamily C, member 16 1.247 2.02E-02
DNAJC8 DnaJ (Hsp40) homolog, subfamily C, member 8 1.228 1.41E-02
ENC1 ectodermal-neural cortex 1 (with BTB domain) −1.203 1.06E-02
DNAJC18 DnaJ (Hsp40) homolog, subfamily C, member 18 1.203 2.90E-02
GSTM2 glutathione S-transferase mu 2 (muscle) −1.199 2.73E-02
FTH1 ferritin, heavy polypeptide 1 1.195 3.25E-02
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 1.190 5.38E-03
AOX1 aldehyde oxidase 1 −1.180 8.24E-03
DNAJC5 DnaJ (Hsp40) homolog, subfamily C, member 5 1.170 4.87E-02
JUN jun proto-oncogene 1.148 1.33E-02
GSTO2 glutathione S-transferase omega 2 −1.147 4.86E-03
STIP1 stress-induced phosphoprotein 1 1.144 2.21E-02
EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3 1.138 4.41E-02
PRKD1 protein kinase D1 −1.132 1.81E-02
MAPK3 mitogen-activated protein kinase 3 1.132 7.71E-05
FOSL1 FOS-like antigen 1 −1.110 1.41E-02
PIK3C3 phosphatidylinositol 3-kinase, catalytic subunit type 3 1.107 1.44E-02
DNAJC11 DnaJ (Hsp40) homolog, subfamily C, member 11 −1.069 4.86E-02
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tumor cell induction of oxidative stress in nearby stromal 
cells [33]. Less is known about adipocytes in the cancer 
microenvironment, though recent studies have described 
“cancer-associated adipocytes”, which exhibit a modified 
phenotype and specific biological features [34], such as 
delipidation, dedifferentiation, and secretion of specific 
adipokines [35, 36]. These effects may be mediated by 
soluble factors released by tumor cells [37, 38]. Ours is the 
first study to our knowledge to identify this phenomenon 
between adipocytes and ALL cells.
Our findings are consistent with other literature 
which highlights the importance of oxidative stress to 
leukemia cell drug response. Inhibition of the oxidative 
stress response has been shown to be cytotoxic and 
enhance chemosensitivity of some leukemia cells [39–41]. 
Bone marrow stromal cells support primary ALL cell 
growth in vitro by providing cysteine, which maintains 
glutathione levels and results in protection against 
oxidative stress [42]. It is possible that adipocytes in bone 
marrow and adipose tissue provide similar protection. 
While these data suggest that soluble factors mediate 
adipocyte protection of ALL cells from oxidative stress, 
we have yet to identify which factors are responsible. 
Among the top 10 genes upregulated in adipocytes 
(Table 1), adrenomedullin (ADM) is a cytokine known to 
be secreted by adipocytes [43], and has been shown to play 
a role in cell survival in several types of cancer [44]. In our 
hands, ADM did not protect 8093 ALL cells from DNR 
treatment (Supplementary Figure S1A), and neutralizing 
ADM antibodies did not block adipocyte protection of 
8093 cells against DNR (Supplementary Figure S1B). 
These results excluded ADM as the relevant survival 
Figure 3: ALL cells induce oxidative stress in adipocytes. (A) Representative fluorescent confocal microscopy images of 3T3-L1 
adipocytes alone, with ALL in TransWells, or treated with 20 mM BSO for 48 hours. Top: DCF (green) only, bottom: DIC images. 
(B) Quantification of fluorescence (FITC) from 3 images similar to A. *indicate t-tests on log-transformed pixel counts. (C) 3T3-L1 gene 
expression by qPCR with (gray bar) and without (white bar) 8093 cells; n = 3. (D) Western blot of HO-1 expression in 3T3-L1 adipocytes 
exposed to DNR, ALL, or both. GAPDH was used as loading control. E. GSH levels measured in media after conditioning with BV173 
ALL cells, 3T3-L1 adipocytes, or both, for 48 hours. *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 5: Glutathione synthesis is partially involved in adipocyte protection of ALL cells. (A) Intracellular GSH quantification 
in 3T3-L1 adipocytes (n = 3). Viable cell number of BV173 and Nalm6 cells treated with DNR (100 and 200 nM, respectively) while co-
cultured with 3T3-L1 (B) or ChubS7 (C) adipocytes that were pre-treated with 20 mM BSO for 24 hours (n = 8–10). (D) Viable cell 
number of BV173 and Nalm6 cells treated with DNR while co-cultured with 3T3-L1 adipocytes that were pre-treated with 250 nM AUR 
for 24 hours (n = 3).*p < 0.05, **p < 0.01, ***p < 0.001 All asterisks indicate comparison to no feeder or vehicle (Veh) conditions unless 
otherwise indicated.
Figure 4: Oxidative stress in adipocytes leads to secretion of survival factors that protect ALL cells from DNR. 
(A) Representative western blot of HIF-1α in ChubS7 adipocytes treated with CoCl2. GAPDH was used as loading control. (B) 3T3-L1 gene 
expression by qPCR with CoCl2 treatment for 24 hours (n = 4). (C) Viable cell number of DNR-treated 8093 ALL cells (left) or BV173 cells 
(right) in the presence of ACM from 3T3-L1 or ChubS7. ACM spiked with CoCl2 were denoted as (+ CoCl2) and ACM conditioned in the 
presence of 30 μM CoCl2 as (w/ CoCl2,  n = 4–8). *P < 0.05 All asterisks indicate comparison to control conditions unless otherwise indicated.
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factor in our experimental system. Other adipocyte-
secreted factors, such as MMP9 and IL8, have been shown 
to have tumor-promoting effects [4]. Therefore, further 
investigation is needed to identify which specific factors 
are responsible for adipocyte protection of ALL cells. 
Another weakness in the current study is that these results 
have not been confirmed in primary human ALL cells, 
nor in vivo. However, the use of multiple human ALL cell 
lines, coupled with our previous results demonstrating the 
effects of adipose tissue ex vivo [13], supports the potential 
importance of these phenomenon to human ALL. 
Along with some of our previous studies [13, 16], 
this work highlights the important role of adipocytes in 
ALL progression and drug resistance. While adipocyte 
protection of ALL cells from oxidative stress is one 
potential mechanisms explaining the association between 
obesity and poor ALL prognosis [7, 9], there are likely 
others. Indeed, we have shown that adipocytes protect 
ALL from multiple chemotherapies [16], some of 
which do not act through induction of oxidative stress. 
In addition, we have found that adipocytes absorb some 
chemotherapies [45], including DNR [46], which could 
contribute to some of the present results, though would 
not explain the protection observed from adipocyte 
conditioned media. Thus, adipocyte protection from 
oxidative stress should be considered when developing 
therapeutic strategies which target oxidative stress in 
cancer cells [41].
MATERIALS AND METHODS
Chemicals and reagents
Daunorubicin (DNR), chaetocin (CTN), buthionine 
sulfoxine (BSO), auranofin (AUR), and other chemicals 
were obtained from Sigma Aldrich. Cell culture media 
components, DCFH-DA (dichloro-dihydro-fluorescein 
diacetate, a fluorimetric probe for oxidative stress 
assessment), and CellROX® reagent were obtained 
from Life Technologies. Fetal bovine serum (FBS) 
was from Denville Scientific. Caspase 3, HIF-1α, and 
GAPDH antibodies were purchased from Cell Signaling 
Technologies. HO-1 antibodies were purchased from 
Abcam. 
Figure 6: Exogenous antioxidants protect ALL cells from DNR. (A) BV173 and Nalm6 treated with DNR or DNR + GSH 
(20 mM, n = 4). (B) BV173 and Nalm6 treated with DNR or DNR + NAC (20 mM, n = 3–4). (C) Cell viability and intracellular ROS 
evaluation using flow cytometry with DAPI and CellROX® staining of BV173 (top two panels) and Nalm6 (bottom two panels) treated with 
DNR alone or DNR and NAC n = 5. *P < 0.05, **P < 0.01, ***P < 0.001 All asterisks indicate comparison to control conditions unless 
otherwise indicated.
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Cell culture
All human ALL cell lines (BV173, RS4;11, 
and Nalm6) and murine pre-adipocyte 3T3-L1 were 
from ATCC. Murine pre-B 8093 ALL cells have been 
previously described [16]. Chub-S7 (immortalized human 
pre-adipose cell line) was from Nestec LTD and cultured 
as previously described [47, 48].
All human ALL cell lines were cultured in RPMI 
1640 (Invitrogen), supplemented with 10% fetal bovine 
serum (FBS), sodium pyruvate (1 mM), Glutamax (2 mM), 
and gentamicin (10 µg/mL). 8093 cells were cultured in 
McCoy’s 5A (Invitrogen), supplemented as above. Fresh 
recombinant murine interleukin-3 (Peprotech) and beta-
mercaptoethanol (Sigma Aldrich) were added to 8093 cells 
at each passage. 3T3-L1 cells were cultured in DMEM high 
glucose (Invitrogen) supplemented with 10% FBS, sodium 
pyruvate (1 mM), Glutamax (2 mM), and gentamicin 
(10 µg/mL). Chub-S7 cells were cultured in DMEM/F12 
(Invitrogen) with 10% FBS, sodium pyruvate (1 mM), 
Glutamax (2 mM), and gentamicin (10 µg/mL). 3T3-L1 
(murine) and ChubS7 (human) pre-adipocytes were 
differentiated into adipocytes as previously described [48].
Co-culture experiments were performed by seeding 
ALL cells in chambers of polycarbonate 0.4 µm pore size 
TransWells (Corning Inc., Corning, NY). The TransWells 
were inserted in plates containing pre-adipocytes or 
adipocytes, such that the ALL cells were not in physical 
contact with the feeder cells.
Conditioned media were made with RPMI1640 
containing 10% FBS. Leukemia cell conditioned media 
(LCM) were made by seeding 200,000 BV173 cells 
per mL in culture for 48 hours. Adipocyte conditioned 
media (ACM) were made by conditioning 100 µL/cm2 
for 48 hours. Adipocyte leukemia cell conditioned media 
(ALCM) were made by seeding 200,000 per mL of BV173 
in co-culture with a monolayer of adipocytes at 100 µL/cm2. 
All media were filtered upon collection using 0.22 µm 
syringe filters (Millipore) and stored at −20°C until use, 
avoiding freeze-thaw cycles.
Gene expression profiling
3T3-L1 adipocytes were cultured in either LCM 
or regular media for 24 hours in biological triplicates. 
RNA was extracted and purified using Qiazol reagent and 
RNEasy Mini Kits as per the manufacturer’s (Qiagen) 
instructions. Microarray hybridization was performed by 
the Genome Core facility at the Saban Research Institute 
of Children’s Hospital Los Angeles (CHLA). RNA quality 
was first assessed using an Agilent Bioanalyzer (Agilent 
Technologies). RNA was then converted to cDNA with 
Superscript Choice for cDNA Synthesis (Invitrogen) and 
then converted to biotinylated cDNA using an Enzo High 
Yield RNA Transcript labeling kit (Enzo Diagnostics). 
GeneChip® Mouse Gene ST Array (Affymetrix) was used 
for hybridization of cDNA. Genes that showed significant 
up/down-regulation (p < 0.05 compared to control 
conditions) in LCM treated samples were analyzed using 
Ingenuity Pathway Analysis (Ingenuity® Systems, www.
ingenuity.com). 
Real-time PCR
Cells were collected and stored with RNAProtect 
(Qiagen) and lyzed with QIAzol (Qiagen). RNA was 
extracted and purified with RNEasy Mini Kits (Qiagen). 
The quantity and quality of extracted RNA was measured 
by NanoVue (Denville Scientific). Two thousand 
nanograms of RNA from each condition were reverse 
transcribed to cDNA with a High Capacity 1st Strand 
Synthesis kit (Applied Biosystems). The expression of 
selected genes was quantified by qPCR using 25 ng of 
cDNA, Power SYBR Select PCR Master Mix (Applied 
Biosystems), and 200 nM primers designed using National 
Center for Biotechnology Information Primer-BLAST 
(See Supplementary Table S1 for primer sequences). 
Gene expression levels were quantified using the ABI 
7900HT Sequence Detection System with the following 
thermal profile: 10 minutes at 95°C followed by 40 repeats 
of 95°C for 15 seconds, 60 degrees for 1 minute, and a 
final dissociation stage of 95°C for 15 seconds, 60°C for 
15 seconds, and 95°C for 15 seconds. Transcript levels 
were normalized to β-actin. Fold change was calculated 
using the ΔΔCt method.
Confocal microscopy
The intracellular ROS assay was done by incubating 
cells with 10 µM DCFH-DA for 15 minutes at 37°C and 
then washing with cold PBS. Samples were imaged at the 
Cellular Imaging Core at the Saban Research Institute of 
CHLA. Briefly, DCF fluorescence images were acquired 
with an LSM 700 confocal system mounted on an 
AxioObserver.Z1 microscope equipped with a 63×/1.4 
Plan-APOCHROMAT objective lens and controlled 
with ZEN 2009 software (Carl Zeiss Microscopy, 
Thornwood, NY). A 488 nm laser and 560 nm long-pass 
filter were used for fluorescence excitation and emission. 
Transmitted laser light was collected to form a DIC image 
simultaneously with the fluorescence image. Images were 
histogram-stretched in a consistent manner to increase 
brightness for publication. Intracellular ROS signals 
from the images were quantified using ImageJ (National 
Institute of Health, Bethesda, MD, USA). 
Western blots
Total protein was extracted from cells using 
protein isolation buffer (62.5 mL Tris-HCL, 2% w/v 
SDS, 1% v/v Igepal CA-630, 10% glycerol, 0.01 mg/mL 
aprotinin, 1 mM phenylmethanesulphonylfluoride, and 
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Phosphatase Inhibitor Cocktail Set II (Calcbiochem)). 
Lysates were sonicated briefly and centrifuged for 
10 minutes at 15,000 g at 4°C. The supernatant was 
retained and protein concentration was quantified by 
BCA assay (Pierce Biotechnology). Equal amounts of 
protein was subjected to SDS-PAGE and transferred to 
a nitrocellulose membrane. Membranes were blocked in 
5% milk and then probed with specific primary antibodies. 
The secondary antibodies used were HRP-linked. Bands 
were detected using a HyGLO-HRP detection kit (Denville 
Scientific, South Plainfield, NJ, USA) and developed with 
HyBLOT-CL Autoradiography Film (Denville Scientific). 
Densitometric band analysis was performed using ImageJ.
Glutathione measurements
The GSH-Glo™ Glutathione Assay (Promega, 
Madison, WI) was used to measure glutathione (GSH) in 
media and on cell extracts, following the manufacturer’s 
instructions. The protein amount of each sample was 
quantified by BCA assay for normalization of GSH.
Flow cytometry
ALL cells were treated with 10 µM DCFH-DA 
for 15 minutes at 37°C, then the reaction was stopped by 
transferring the cells on ice and protecting from light. Then 
DAPI was added to distinguish live cells. The samples 
were run at the Fluorescence Activated Cell Sorting Core 
at CHLA on LSR II Analyzer from Becton Dickinson (BD). 
The PE channel was used to detect intracellular DNR and 
the FITC channel for DCF. Proper compensation controls 
were used to calculate spill over between PE and FITC 
channels. In other experiments where CellROX® Deep Red 
Reagent (Life Technologies) was used, the APC channel 
was used to detect CellROX®. For apoptosis analysis, ALL 
cells were harvested and stained with 25 ng APC-conjugated 
Annexin V for 15 minutes at room temperature. Then 50 ng 
DAPI was added to stain for late apoptotic/necrotic cells. 
The samples were run on the same analyzer above.
Statistical analysis
All statistical tests were performed with Microsoft 
Excel 2010. The data are presented as mean ± Standard 
Deviation. Experimental  groups were compared using 
paired, two-sided t-tests; non-normally distributed data 
was log-transformed prior to t-test. A p value of less than 
0.05 was taken as statistically significant. Flow cytometry 
of intracellular DNR and DCF were quantified using 
median fluorescence intensity (MFI). MFI was calculated 
by dividing sample fluorescence signals by the control 
signal. All experiments were performed in triplicates and 
repeated at least three times. All graphs are presented as 
mean ± SD.
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